Calls for papers
-
Florida-based Nephron Pharmaceuticals has announced that it is launching an over-the-counter racepinephrine inhalation solution delivered by a device called the EZ Breathe Atomizer. The product will be marketed as Asthmanefrin and is being promoted as… Read more . . .
-
Watson Pharmaceuticals has launched a generic levalbuterol inhalation solution, an authorized version of Sunovion’s Xopenex for the treatment of asthma. Shipments will begin immediately. The company cites IMS Health data saying that sales of Xopenex… Read more . . .
-
Astellas and AstraZeneca have announced the approval of Symbicort Turbuhaler for COPD. The budesonide/formoterol fumarate DPI has been available for the treatment of asthma in Japan since January 2010. The two companies entered an agreement… Read more . . .
-
According to a newspaper report, Novartis has confirmed that it will retain its respiratory disease research center in Horsham, UK, with 440 employees. The company will sell a portion of the site and plans to… Read more . . .
-
GE Capital Healthcare Financial Services has announced today that it is providing $7.5 million in financing to Trimel Pharmaceuticals for Phase 2 and 3 clinical development of several OINDPs. Trimel’s pipeline includes asthma and allergic… Read more . . .
-
Lightlake Therapeutics has announced what it called “very encouraging preliminary results” from a Phase 2 clinical trial of its naloxone nasal spray for the treatment of binge eating disorder. According to the company, the randomized,… Read more . . .
-
Israeli biopharmaceutical company Kamada will receive milestone payments of $60 million as part of a 12-year distribution agreement with Chiesi Farmaceutici for Kamada’s inhaled alpha-1 antitrypsin for the treatment of alpha-1 antitrypsin deficiency (AATD-IH). Chiesi… Read more . . .
-
According to Insmed, the US Patent and Trademark Office has issued the company a second composition of matter patent for Arikace liposomal amikacin for inhalation, US Patent No. 8,226,975. Insmed is developing the product for… Read more . . .
-
Inhaled drug company Alexza Pharmaceuticals has announced the promotions of four executives. The company has promoted James V. Cassella to Executive VP, Research and Development and Chief Scientific Officer; Darl Moreland to Senior VP, Quality;… Read more . . .
-
Melbourn Scientific has added a Proveris SprayVIEW system and Vereo actuator, making the contract research organization the first in Europe to offer cGMP spray pattern and plume geometry measurements required for nasal spray and MDI… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK